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approach with appropriate broad 
spectrum antibiotics, and specific 
treatment initiated based on the 
culture report, followed by splenec-
tomy after appropriate vaccinations. 
Since the functional residual splenic 
tissue in massive splenic infarction 
is minimal, splenectomy is not ex-
pected to worsen the hyopsplenic 
state postoperatively. The recom-
mended indications for splenecto-
my in patients with massive splenic 
infarction are persistent upper ab-
dominal pain, pressure symptoms 
of a large spleen, accidental rupture 
and the concern of potential risk of 
infection, or the presence of an ab-
scess of the infarcted splenic tissue. 
Splenectomy could, however, pose 
special technical problems due to 
the size of the spleen and surround-
ing perisplenic inflammation. Dense 
adhesions are usually seen between 
the spleen, diaphragm, stomach 
and perinephric region. This makes 
laparascopic splenctomy a relative 
contraindication.10 Dissection could 
be partly facilitated by decompress-
ing the cystic mass intraoperatively 
by aspiration, while taking precau-
tion to avoid spillage of splenic tis-
sue into the peritoneal cavity, as we 
did in our second case.
In conclusion, massive splenic 
infarction is rare, and constituted 
approximately 3.8% of patients who 
required splenectomy for splenic se-
questration in this large single insti-
tution study. All our three patients 
with massive splenic infarction were 
adults with persistent splenomegaly 
well into adulthood, making them 
liable to this complication. An el-
evated HbF is an important risk 
factor that is significantly associated 
with massive splenic infarction. A 
potential complication of a massive 
infarcted spleen is splenic abscess. 
A high index of clinical suspicion 
supported by radiological evidence 
on ultrasound and CT scan would 
help early, prompt and appropriate 
management. Splenic aspiration 
may be warranted in some of these 
cases. These patients can be man-
aged initially by conservative mea-
sures followed by splenectomy. The 
predominant indication for splenec-
tomy would be persistent pain, pres-
sure effects and the risk of infection 
of the infarcted splenic tissue. 
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Uterine sarcoma: a rare 
cause of uterine inversion
To the Editor: We describe a case 
of uterine inversion associated with 
endometrial sarcoma. Initially, the 
patient was thought to have a cer-
vical mass, as she developed severe 
bleeding and the mass protruded 
outside the vagina. A CT scan was 
done before examination under 
anesthesia, with findings of a large 
uterine mass. We performed a to-
tal abdominal hysterectomy and 
bilateral salpingo-oophorectomy. 
A completely inverted uterus was 
found during surgery. Histology 
showed adenosarcoma of the en-
dometrium. The tumor was limited 
to the endometrium. At the 5-year 
follow up, there was no clinical or 
radiological evidence of recurrent 
disease. Uterine sarcoma should be 
suspected in uterine inversion diag-
nosed in a postmenopausal woman. 
Most cases of uterine inversion are 
obstetric related and encountered 
during the puerperium. Non-puer-
peral uterine inversion is estimated 
to account for just 17% of all cases 
of uterine inversion.1 Benign uter-
ine pathology may present as uter-
ine inversion (submucosal myoma 
is a good example).2 Rarely, uterine 
inversion may complicate the pre-
sentation of uterine sarcoma.6-12 
The differential diagnosis of uter-
ine inversion in a postmenopausal 
woman should include uterine pa-
thology, particularly sarcoma. 
A 76-year-old woman was ad-
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mitted through the emergency 
department with postmenopausal 
bleeding and lower abdominal pain 
for six weeks prior to her presenta-
tion. She was obese with a BMI of 
31. The patient was known to have 
high blood pressure and cardio-
myopathy. A CT scan suggested 
a mass involving the upper vagina 
and surrounding the lower uterine 
segment and cervix with air also in 
the endometrial canal that may have 
represented endometritis, although 
extension from the endometrial ca-
nal into the cervix could not be ex-
cluded. The patient developed pro-
fuse vaginal bleeding and a 10-cm 
mass protruded outside the vagina. 
The on-call team managed her by 
applying a suture ligature around 
the pedicle, which controlled the 
bleeding. Examination under an-
esthesia was done and a huge mass 
in the vagina was found. The cervix 
could not be visualized and the uter-
us was enlarged. A biopsy was taken 
of the mass and histological exami-
nation indicated adenosarcoma of 
the endometrium. Total abdominal 
hysterectomy, a bilateral salpingo-
oophorectomy and a bilateral pel-
vic lymphadenectomy were done. 
During laparotomy, a completely 
inverted uterus was found with a 
fungating necrotic mass expand-
ing the vagina. The inverted uterus 
demonstrated the characteristic 
uterine dimple at the uterine fundus 
(Figure 1). The final histopathology 
was adenosarcoma of the endome-
trium with a clear margin (Figure 
2). Postoperatively, the patient re-
covered well and follow-up, both 
clinically and by CT scan, showed 
no evidence of recurrence. The last 
CT scan in October 2009 (5 years 
from the diagnosis) showed no evi-
dence of local or distant recurrence. 
Non-puerperal uterine inversion 
is an extremely rare disease, account-
ing for only one sixth of all cases of 
inversion.2 Takeno et al. reported 
that the frequency of nonpuerperal 
uterine inversion with endometrial 
carcinoma was 6.8% (71.6% were 
leiomyomas, 13.6% were sarcoma, 
and 8.0% were idiopathic).1 It is 
extremely difficult to preoperatively 
diagnose nonpuerperal uterine in-
Figure 1. uterine inversion at time of laparotomy with uterine dimple at  the uterine 
fundus indicating the inversion.
version, and the diagnosis is often 
made at time of surgery. Particularly 
in postmenopausal women, uterine 
inversion with corpus malignancy 
can be misdiagnosed as a cervical 
malignancy.4 Furthermore, it has 
been described that the symptoms 
Figure 2. Histopathology of endometrial adenosarcoma.
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associated with a nonpuerperal 
uterine inversion were vaginal bleed-
ing, vaginal tumor, lower abdominal 
pain, menorrhagia and urinary dis-
turbance. Including our cases, none 
of the reported cases were in shock, 
which is sometimes associated with 
puerperal uterine inversion.
Uterine inversion is suspected 
when a tumor is palpable in the va-
gina, but the uterine fundus is not 
palpable by a pelvic examination.5 
In the present case, extruded tumor 
was observed in the vagina, but a 
pelvic examination failed to identify 
uterine inversion. MRI has been 
shown to be a useful diagnostic 
tool since it can examine the char-
acteristic image of the uterine cavity 
and a thickened and inverted uter-
ine fundus on a sagital image and a 
‘bulls eye’ configuration on an axial 
image are signs indicative of uterine 
inversion.12 Our case was diagnosed 
by CT scan, but inversion was not 
suspected by CT. The diagnosis of 
uterine inversion was made during 
the surgical procedure.
The etiological factors of this 
combination include (a) sudden ex-
trusion of a tumor from the uterus, 
(b) thin uterine wall, (c) dilatation 
of the uterine cervix, (d) tumor size, 
(e) thickness of the tumor pedicle 
and (f ) tumor attachment site.3 In 
our case, as the tumor with its ped-
icle attached to the uterine muscle 
became progressively relaxed at the 
point of pedicle attachment, the cer-
vix dilated and the tumor extruded 
into the vagina, resulting in uterine 
inversion. When a rapidly growing 
tumor exhibits signs indicative of 
myoma delivery, patients should be 
treated as having not only uterine 
sarcoma, but also uterine inversion.
Ehrlich et al. reported that the 
abdominal approach is the best 
and least hazardous treatment for 
uterine inversion caused by uter-
ine sarcoma.5 Since patients with 
this disease are less likely to suffer 
shock, there is enough time to per-
form tests such as MRI to deliver 
an accurate preoperative diagnosis. 
However, in our case the severe 
vaginal bleeding and mass protrud-
ed outside the vulva, which made 
surgical intervention life saving. At 
present, surgery and/or chemo-
therapy have been recommended 
for the treatment of uterine inver-
sion caused by sarcoma, but the 
standard therapy has not yet been 
established. Therefore, treatment 
options for this combination should 
be studied in the future.
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Lead intoxication mimick-
ing a malignancy 
To the Editor: A 51-year-old male 
presented to the hospital with a 3-
month history of low to moderate 
grade fever, fatigue, weight loss and 
upper abdominal pain. Clinical 
examination was unremarkable 
except mild pallor. Investigations 
revealed low hemoglobin (9.8 g/
dL) with normal blood counts and 
elevated transminase levels (SGOT: 
345U/L, SGPT: 123 U/L). Other 
biochemical parameters were nor-
mal. Blood and urine cultures were 
sterile. CT of the abdomen revealed 
pericholecystic fluid, favoring a 
diagnosis of chronic cholecystitis 
with acute exacerbation. He un-
derwent laparoscopic cholecystec-
tomy along with a wedge biopsy of 
liver. Liver biopsy showed only fatty 
change. In view of no response to 
broad-spectrum oral antibiotics he 
was further investigated. Contrast-
enhanced CT of the chest showed 
bilateral parenchymal infiltrates 
with mediastinal lymphadenopathy. 
During the course of investigation 
he started developing pancytopenia. 
The presence of mediastinal nodes 
and cytopenias raised a suspicion 
of lymphoma with marrow involve-
ment. A trial of naproxen further 
